meta content='width=device-width, initial-scale=1.0' name='viewport'/>

Tuesday, August 23, 2016

CRYPTOCOCCOSIS IN AIDS IN NATO STATES


The new Cryptococcus gattii fungus strain, magnified. Photo: Courtesy of Edmond Byrnes and Joseph Heitman, Duke Department of Molecular genetics and Microbiology

The new Cryptococcus gattii fungus strain, magnified.
Photo: Courtesy of Edmond Byrnes and Joseph Heitman, Duke Department of Molecular genetics and Microbiology 


Despite the prevalence of cryptococcosis worldwide, cryptococci very rarely cause diseases. During intentional immunosuppressing , for example in the case of organ transplants and immunosuppressing diseases, they were documented in one hospital in South Africa, and there in only 1% cases.

Only the droppings of each 100th pet bird can be regarded as a natural source of infection. In New York, 6% of AIDS patients cryptococcosis. The largest incidence was in New Jersey with 11%. The higher prevalence of cryptococcal meningitis in New York may result largely from the large proportion of AIDS patients in this state who are black.

Otherwise, the rate of cryptococcosis incidences in the USA among AIDS patients is 5%. Although cured by the highly effective Amphotericin B, it nonetheless frequently recurs in AIDS patients. This must be the result of a new intentional supply.

In a district of Paris with a considerable number of AIDS patients, 69% of those healthy persons living there had antibodies against this extremely rare fungus, but only 22% of the HIV patients living there had the relevant antibodies.

The agent must, therefore, have been intentionally spread at a time when 47% of HIV-infected patients already were not able to develop antibodies to this. What was to them? A new agent.

No comments:

Post a Comment